Accelerating High Throughput Experimentation Workflows using Automated Data Processing
Join us for an engaging webinar on high throughput analytical data management featuring Holly Douglas, Senior Research Scientist from AstraZeneca.Discover how integrating the Reaction Optimization software solution is revolutionizing drug discovery by streamlining workflows and enhancing data quality. Register now for valuable insights into the future of high throughput experimentation.
We are excited to invite you to an insightful webinar titled “Accelerating High Throughput Experimentation Workflows using Automated Data Processing”, featuring Holly Douglas, Senior Research Scientist at AstraZeneca.
In this webinar, Holly will showcase how the integration of the Reaction Optimization software solution is revolutionizing synthetic workflow in drug discovery.
Discover how this innovative approach eliminates data processing bottlenecks, enhances data quality, and sets new standards for efficiency and reliability in high throughput experimentation.
Who Should Attend:
- Organic, medicinal, or process chemists seeking to streamline their analytical workflows and enhance efficiency.
- Lab or project managers interested in optimizing laboratory productivity by implementing innovative software solutions.
- Scientists dealing with large volumes of analytical data, eager to explore automation possibilities.
SESSION 1 Wednesday, June 5th, 2024
4:00 pm CEST/10:00 am EDT/7:00 am PDT - Register Here
SESSION 2 Thursday, June 6th, 2024
10:00 am CEST/2:30 pm IST/6:30 pm ACST - Register Here
Presenter: Holly Douglas (Senior Research Scientist, AstraZeneca)
Holly has a broad range of experience applying analytical chemistry techniques to a variety of research projects. The majority of Holly’s experience has been in the pharmaceutical industry having worked as an analytical chemist at GSK, Novartis and the MHRA, with roles based in drug discovery, process chemistry and final product testing. More recently Holly has worked at Owlstone Medical where she developed separation and detection methods for identifying volatile biomarkers in breath samples and the Francis Crick Institute where she was involved in the LC-MS investigation of the metabolomics and drug resistance of Mycobacterium tuberculosis.
